<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04688554</url>
  </required_header>
  <id_info>
    <org_study_id>200209</org_study_id>
    <nct_id>NCT04688554</nct_id>
  </id_info>
  <brief_title>Psychosocial, Behavioral, and Radiologic Changes Following Radiosurgery for Benign Neurologic Disease</brief_title>
  <official_title>Psychosocial, Behavioral, and Radiologic Changes Following Neurologic Events or Interventions: A Prospective, Non-Interventional, Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Varian Medical Systems</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A number of studies from the literature suggest important behavioral, psychosocial, or&#xD;
      radiologic changes occur following significant neurologic events or interventions such as&#xD;
      stroke, neurosurgery, medications, radiation, systemic therapy, or injury. The purpose of&#xD;
      this study is to describe these changes with advanced neurologic imaging and targeted&#xD;
      neurologic and neuropsychiatric assessments. This is a non-interventional observational study&#xD;
      of minimal risk to participants as there is no medical intervention. The results of this&#xD;
      study will be used to inform patients, scientists, and society in the development of future&#xD;
      treatments.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Functional magnetic resonance imaging (fMRI) and diffusion tensor tractography (DTI) have&#xD;
      rapidly expanded since its emergence two decades ago. fMRI is well established as the single&#xD;
      most powerful method for detecting changes in neural activity in vivo, albeit indirectly by&#xD;
      detection of changes in blood oxygenation level dependent (BOLD) signals that reflect&#xD;
      hemodynamic changes subsequent to neural activity. A conventional fMRI experiment involves&#xD;
      the comparison of two or more brain states followed by statistical tests to identify which&#xD;
      brain regions were involved in a particular task. The identification of patterns of highly&#xD;
      correlated low-frequency MRI signals in the resting brain provides a powerful approach to&#xD;
      delineate and describe neural circuits, and an unprecedented ability to assess the manner in&#xD;
      which distributed regions work together to achieve specific functions. Since the first&#xD;
      reports of temporal correlations in BOLD baseline signals, several distinct cortical&#xD;
      long-range networks have been identified and characterized in the resting state, including a&#xD;
      default mode network. Moreover, observations of altered resting state connectivity in several&#xD;
      disorders and as a function of behavior or cognitive skills suggest these correlations&#xD;
      reflect an important level of brain organization and may play a fundamental role in the&#xD;
      execution and maintenance of various brain functions. DTI is also an exceedingly important&#xD;
      imaging modality that has elucidated the neural connectivity inherent between various&#xD;
      cortical and subcortical structures. DTI is routinely used and has enhanced our understanding&#xD;
      of functional connections between various parts of the brain. Prior to interventions, DTI is&#xD;
      commonly obtained, so that interventionists can avoid critical circuitry. There is suggestion&#xD;
      that both fMRI and DTI imaging is influenced by organic or interventional variables, however&#xD;
      this is understudied. The neuroscientists and clinicians would greatly value information that&#xD;
      would expand our working knowledge of the basic neural substrates and functional neural&#xD;
      changes that occur in patients organically or after interventions. A non-invasive,&#xD;
      non-interventional, observational study is needed to show the changes that happen to patients&#xD;
      organically or in standard of care settings. A greater working understanding of the neural&#xD;
      connectivity and changes that happen in the brain is of great future benefit to patients,&#xD;
      science, and society as well as future therapeutic development such as post-stroke care,&#xD;
      rehabilitation, post-traumatic brain injury, or post-treatment care in the brain that has&#xD;
      previously been influenced by intervention or disease.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 25, 2020</start_date>
  <completion_date type="Anticipated">August 25, 2025</completion_date>
  <primary_completion_date type="Anticipated">August 25, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Describe changes in Obsessive Compulsive Disorder disease burden after stereotactic radiosurgery.</measure>
    <time_frame>Every 3 months for 1 year or through study completion</time_frame>
    <description>Yale-Brown Obsessive Compulsive Scale questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Describe changes in Depression disease burden after stereotactic radiosurgery.</measure>
    <time_frame>Every 3 months for 1 year or through study completion</time_frame>
    <description>Beck's Depression inventory</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Describe changes in Pain disease burden after stereotactic radiosurgery.</measure>
    <time_frame>Every 3 months for 1 year or through study completion</time_frame>
    <description>McGill Pain Scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Describe changes in cognition after stereotactic radiosurgery.</measure>
    <time_frame>Every 3 months for 1 year or through study completion</time_frame>
    <description>Montreal Cognitive Assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Describe changes in radiologic parameters after stereotactic radiosurgery.</measure>
    <time_frame>Every 6 months for 1 year or through study completion</time_frame>
    <description>Brain MRI</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Obsessive-Compulsive Disorder</condition>
  <condition>Pain, Intractable</condition>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Refractory Obsessive Compulsive Disorder</arm_group_label>
    <description>fMRI, DTI, behavioral, psychological, and disease-specific changes following radiosugical capsulotomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Refractory Pain</arm_group_label>
    <description>fMRI, DTI, behavioral, psychological, and disease-specific changes following radiosugical cingulotomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Refractory Tremor</arm_group_label>
    <description>fMRI, DTI, behavioral, psychological, and disease-specific changes following radiosugical thalamotomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Refractory Depression</arm_group_label>
    <description>fMRI, DTI, behavioral, psychological, and disease-specific changes following radiosugical cingulotomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>fMRI and DTI</intervention_name>
    <description>Neurologic imaging correlates</description>
    <arm_group_label>Refractory Depression</arm_group_label>
    <arm_group_label>Refractory Obsessive Compulsive Disorder</arm_group_label>
    <arm_group_label>Refractory Pain</arm_group_label>
    <arm_group_label>Refractory Tremor</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Behavioral questionnaires</intervention_name>
    <description>RAND 36-item Quality of Life survey, Mini Mental Status Exam, MOCA Cognitive Exam</description>
    <arm_group_label>Refractory Depression</arm_group_label>
    <arm_group_label>Refractory Obsessive Compulsive Disorder</arm_group_label>
    <arm_group_label>Refractory Pain</arm_group_label>
    <arm_group_label>Refractory Tremor</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Disease-Specific Patient-Reported Outcomes</intervention_name>
    <description>Y-BOCS Survey, QUEST, PDQ39, PHQ2 Depression Screening, PHQ9 Depression Inventory, Beck's Depression Inventory, PROMIS Pain Intensity Short Form 3, McGill Pain Scale, Visual Analog pain scale, FTM (Tremor Scale)</description>
    <arm_group_label>Refractory Depression</arm_group_label>
    <arm_group_label>Refractory Obsessive Compulsive Disorder</arm_group_label>
    <arm_group_label>Refractory Pain</arm_group_label>
    <arm_group_label>Refractory Tremor</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Behavioral tests</intervention_name>
    <description>Behavioral tests may include one or more of the following procedures: Upper extremity testing, Perdue Peg Board testing, Hand tactile detection and discrimination test, Temperature and pain threshold testing, Lower extremity Testing, Myomotion Inertial Motion Testing.</description>
    <arm_group_label>Refractory Depression</arm_group_label>
    <arm_group_label>Refractory Obsessive Compulsive Disorder</arm_group_label>
    <arm_group_label>Refractory Pain</arm_group_label>
    <arm_group_label>Refractory Tremor</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        VUMC adult patients with neurologic disease or patients with neurologic interventions such&#xD;
        as neurosurgical procedures or radiation therapy. Men and women of any ethnicity, race or&#xD;
        socioeconomic status who meet inclusion criteria will be offered enrollment into the study.&#xD;
        Patient will be greater than 18 years of age and meet inclusion and exclusion criteria.&#xD;
        Patients eligible for this study will include patients with neurologic events, including&#xD;
        but not limited to stroke, depression, infections, psychiatric disease. Intervention is not&#xD;
        part of this study, however, patients receiving neurologic interventions, such as&#xD;
        neurosurgical procedures or radiation therapy, would be eligible.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age â‰¥ 18 years old and willing and able to sign a written informed consent.&#xD;
&#xD;
          -  Eligible for Brain MRI&#xD;
&#xD;
          -  History of neurologic event or intervention OR future planned neurologic intervention&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindications to MRI of the brain&#xD;
&#xD;
          -  Patient declining participation in study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed H Khattab, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anthony J Cmelak, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohamed H Khattab, MD</last_name>
    <phone>(615) 322-2555</phone>
    <email>mohamed.khattab@vumc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alexander D Sherry, MD</last_name>
    <phone>(615) 322-2555</phone>
    <email>alexander.d.sherry@vanderbilt.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232-5671</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed H Khattab, MD</last_name>
      <phone>615-322-2555</phone>
      <email>mohamed.khattab@vumc.org</email>
    </contact>
    <investigator>
      <last_name>Mohamed H Khattab, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anthony J Cmelak, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>William Petrie, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jonathan E Becker, DO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexander D Sherry, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>September 16, 2020</study_first_submitted>
  <study_first_submitted_qc>December 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 30, 2020</study_first_posted>
  <last_update_submitted>December 24, 2020</last_update_submitted>
  <last_update_submitted_qc>December 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Mohamed Khattab</investigator_full_name>
    <investigator_title>Chief Resident, Department of Radiation Oncology</investigator_title>
  </responsible_party>
  <keyword>Stereotactic Radiosurgery</keyword>
  <keyword>Cingulotomy</keyword>
  <keyword>Capsulotomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Intractable</mesh_term>
    <mesh_term>Compulsive Personality Disorder</mesh_term>
    <mesh_term>Obsessive-Compulsive Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Research data will be shared upon reasonable request to the principal investigator.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Data will become available after the publication of the study results.</ipd_time_frame>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 18, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/54/NCT04688554/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

